Aliases & Classifications for Dysentery

MalaCards integrated aliases for Dysentery:

Name: Dysentery 12 44 15 73
Infectious Diarrhea 12 55 63

Classifications:



Summaries for Dysentery

PubMed Health : 63 About infectious diarrhea: Diarrhea is very common: In Germany, for instance, adults get it once a year on average, and it is even more common in children. It is usually caused by viruses, the most common of which are the highly contagious norovirus and rotavirus. Infectious diarrhea can also come from bacteria such as Salmonella or Campylobacter.In normal cases of diarrhea, you can usually just replace the fluids you lose and wait until the infection goes away. But more severe or longer lasting diarrhea needs to be treated because it can lead to the loss of dangerously high levels of fluid and salt, especially in young children and older people.

MalaCards based summary : Dysentery, also known as infectious diarrhea, is related to shigellosis and abdominal tuberculosis, and has symptoms including diarrhea An important gene associated with Dysentery is TF (Transferrin). The drugs Omeprazole and Azithromycin have been mentioned in the context of this disorder. Affiliated tissues include colon, liver and testes.

Disease Ontology : 12 An intestinal infectious disease that involves inflammation of the intestines, especially colon, due to chemical irritants, bacteria, protozoa, or parasitic worms, which results in severe diarrhea with passage of mucus and blood.

Wikipedia : 76 Dysentery is an inflammatory disease of the intestine, especially of the colon, which always results in... more...

Related Diseases for Dysentery

Diseases related to Dysentery via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 165)
# Related Disease Score Top Affiliating Genes
1 shigellosis 32.1 CD79A LTF TTR
2 abdominal tuberculosis 30.9 ALB CRP
3 appendicitis 30.3 ALB CRP ENO2
4 deficiency anemia 30.0 ALB CRP HP TF
5 protozoal dysentery 12.2
6 amebiasis 12.0
7 balantidiasis 11.5
8 campylobacteriosis 11.1
9 folic acid deficiency anemia 10.9 CRP TF
10 pyuria 10.9 ALB CRP
11 paramyloidosis 10.9 ALB TTR
12 acquired angioedema 10.8 CRP HP
13 median rhomboid glossitis 10.8 TF TTR
14 burns 10.8 ALB TTR
15 chronic inflammatory demyelinating polyneuropathy 10.8 HP TTR
16 ariboflavinosis 10.8 ALB TF
17 congenital disorder of glycosylation, type ia 10.8 HP TF
18 aleutian mink disease 10.7 ALB TTR
19 bronchus cancer 10.7 CRP ENO2
20 amyloidosis aa 10.7 CRP TTR
21 tuberculous peritonitis 10.7 ALB CRP
22 hyperthyroxinemia 10.7 ALB TTR
23 splenic abscess 10.7 CRP IER3IP1
24 chronic pulmonary heart disease 10.6 HP TTR
25 rheumatic myocarditis 10.6 CRP IL1A
26 superficial siderosis of the central nervous system 10.6 LTF TF
27 uremia 10.6 ALB CRP TF
28 cork-handlers' disease 10.6 ALB CD79A
29 superficial siderosis 10.6 LTF TF
30 ostertagiasis 10.6 ALB CD79A
31 pure red-cell aplasia 10.6 ALB TF
32 dermatitis, atopic, 3 10.6 ALB CD79A
33 kwashiorkor 10.6 ALB TF TTR
34 splenic disease 10.6 ALB IER3IP1
35 trypanosomiasis 10.6 ALB HP TF
36 intestinal tuberculosis 10.6 CD79A CRP
37 chronic ulcer of skin 10.6 ALB CRP TTR
38 haemophilus influenzae 10.6 LTF TF
39 decubitus ulcer 10.6 ALB CRP TTR
40 orthostatic proteinuria 10.6 ALB CD79A
41 cryofibrinogenemia 10.6 CD79A HP
42 acute maxillary sinusitis 10.5 CD79A CRP
43 papillary ependymoma 10.5 ENO2 TTR
44 autonomic nervous system disease 10.5 ALB TTR
45 radiation proctitis 10.5 LTF TF
46 geniculate herpes zoster 10.5 CD79A HP
47 diffuse glomerulonephritis 10.5 ALB CD79A
48 carotenemia 10.5 CD79A TTR
49 respiratory failure 10.5 ALB CRP TTR
50 focal dermal hypoplasia 10.5 ALB CD79A

Comorbidity relations with Dysentery via Phenotypic Disease Network (PDN):


Acute Cystitis

Graphical network of the top 20 diseases related to Dysentery:



Diseases related to Dysentery

Symptoms & Phenotypes for Dysentery

UMLS symptoms related to Dysentery:


diarrhea

Drugs & Therapeutics for Dysentery

PubMedHealth treatment related to Dysentery: 63

You lose fluids and electrolytes when you have diarrhea, so it is important to replace them. For acute, non-severe diarrhea you usually just need something like tea with sugar and some salted crackers. Foods that are gentle on the stomach is recommended too, such as rice, bananas or rusk bread. Some people also avoid coffee, fruit juices, sodas, alcohol and fatty foods to keep from irritating their bowel even more.Acute, non-severe diarrhea does not require special treatment in adults and teenagers. But it is a good idea for young children and older people, as well as people with more severe diarrhea, to replace fluids and electrolytes by using oral rehydration salts (electrolyte/glucose solutions) from the pharmacy. These are powders containing salts, minerals and glucose that can be dissolved in water. If these solutions are not available (for instance, while traveling) the following ingredients can be stirred into one liter of bottled or boiled water:Five tablespoons of sugarOne and a half level tablespoons of saltOne glass of packaged orange juiceIn addition to drinking fluids and using other treatments, foods or dietary supplements that have probiotic microorganisms (probiotics) in them can help to make the diarrhea go away faster.Depending on how severe the symptoms are and how long they last, other treatments may be considered too:Drugs like loperamide or racecadotril can help to slow down the activity of the bowel and lower the number of times you need to go to the bathroom. Loperamide is not suitable for children under the age of twelve years, and racecadotril is prescription-only for children.Sometimes certain types of yeast tablets (Perenterol) are also recommended. These tablets are thought to help the body get rid of the germs faster and to support natural gut flora. Charcoal tablets dissolved in water can also be taken to relieve diarrhea symptoms. But there is a lack of good-quality research in this area so no conclusions can be drawn about the benefits and harms of these treatment options.Antibiotics are only an option if the infection is bacterial. They can't fight viruses.

Drugs for Dysentery (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 155)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Omeprazole Approved, Investigational, Vet_approved Phase 4 73590-58-6 4594
2
Azithromycin Approved Phase 4,Not Applicable 83905-01-5 55185 447043
3
Loperamide Approved Phase 4,Phase 3,Not Applicable 53179-11-6 3955
4
Rifaximin Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 80621-81-4 6436173
5
Mebendazole Approved, Vet_approved Phase 4 31431-39-7 4030
6
Piperazine Approved, Vet_approved Phase 4 110-85-0 4837
7
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613
8
Citric Acid Approved, Nutraceutical, Vet_approved Phase 4 77-92-9 311
9 Anti-Bacterial Agents Phase 4,Phase 2,Phase 3,Not Applicable
10 Antibiotics, Antitubercular Phase 4,Phase 2,Phase 3
11 Anti-Infective Agents Phase 4,Phase 2,Phase 3,Not Applicable
12 Antiparasitic Agents Phase 4,Phase 3,Phase 2
13 Antitubercular Agents Phase 4,Phase 3
14 Antacids Phase 4,Phase 1
15 Anti-Ulcer Agents Phase 4,Phase 1
16 Gastrointestinal Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
17 Proton Pump Inhibitors Phase 4
18 Antidiarrheals Phase 4,Phase 3,Not Applicable
19 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 2,Phase 3,Not Applicable
20 rifamycin SV Phase 4,Phase 2,Phase 3,Not Applicable
21 Rifamycins Phase 4,Phase 2,Phase 3,Not Applicable
22 Anthelmintics Phase 4
23 Antimitotic Agents Phase 4
24 Piperazine citrate Phase 4
25 Amoxicillin-Potassium Clavulanate Combination Phase 4
26 beta-Lactamase Inhibitors Phase 4
27 Clavulanic Acid Phase 4
28 Acidophilus Nutraceutical Phase 4,Phase 3,Phase 1,Phase 2
29 Cola Nutraceutical Phase 4,Not Applicable
30 Citrate Nutraceutical Phase 4
31
Ciprofloxacin Approved, Investigational Phase 3,Phase 2 85721-33-1 2764
32
Iron Approved Phase 3,Phase 2,Not Applicable 7439-89-6 23925
33
Zinc Approved, Investigational Phase 3,Phase 2,Not Applicable 7440-66-6 23994
34
Zinc sulfate Approved, Investigational Phase 3 7733-02-0
35
Nitazoxanide Approved, Investigational, Vet_approved Phase 3,Phase 2 55981-09-4 41684
36
Terlipressin Approved, Investigational Phase 3 14636-12-5 72081
37
Lactulose Approved Phase 2, Phase 3 4618-18-2 11333
38
Irinotecan Approved, Investigational Phase 3 97682-44-5, 100286-90-6 60838
39
Folic Acid Approved, Nutraceutical, Vet_approved Phase 3,Not Applicable 59-30-3 6037
40
leucovorin Approved, Nutraceutical Phase 3,Not Applicable 58-05-9 143 6006
41
Vitamin A Approved, Nutraceutical, Vet_approved Phase 3,Not Applicable 11103-57-4, 68-26-8 445354
42 Cytochrome P-450 CYP1A2 Inhibitors Phase 3,Phase 2,Not Applicable
43 Cytochrome P-450 Enzyme Inhibitors Phase 3,Phase 2,Not Applicable
44 Topoisomerase Inhibitors Phase 3,Phase 2,Not Applicable
45 Antirheumatic Agents Phase 3,Phase 2,Phase 1
46 Antibodies Phase 3
47 Immunoglobulins Phase 3
48 Vaccines Phase 3,Phase 1,Phase 2,Not Applicable
49 Micronutrients Phase 3,Phase 2,Not Applicable
50 Trace Elements Phase 3,Phase 2,Not Applicable

Interventional clinical trials:

(show top 50) (show all 105)
# Name Status NCT ID Phase Drugs
1 New Hypo-Osmolar ORS (Recommended by WHO) for Routine Use in the Diarrhea Management– Surveillance Study for Adverse Effects Completed NCT00490932 Phase 4 Hypo-osmolar ORS
2 Effects of Gastric Acid on Colonic Microbiome Completed NCT01901276 Phase 4 Omeprazole 40 mg bid
3 Azithromycin, With or Without Loperamide, to Treat Travelers' Diarrhea Completed NCT00359970 Phase 4 Azithromycin 500 mg;Azithromycin 1000 mg;Loperamide
4 Rifaximin, Loperamide and the Combination to Treat Travelers' Diarrhea Completed NCT00292344 Phase 4 Rifaximin and loperamide
5 Study to Evaluate Efficacy and Safety of a Double Treatment Plan Using a Combination of Mebendazole and Quinfamide for Treating Intestinal Helminthiasis and Amebiasis in the Mexican Population Completed NCT02385058 Phase 4 Mebendazole;Quinfamide;Placebo
6 Lactobacillus Reuteri DSM 17938 in the Prevention of Antibiotic-associated Diarrhea in Children: Protocol of a Randomized Controlled Trial Completed NCT02871908 Phase 4 Lactobacillus reuteri DSM 17938;Placebo
7 Effect of Lactobacillus Reuteri DSM 17938 to Prevent Antibiotic-associated Diarrhea in Children Recruiting NCT02765217 Phase 4 Lactobacillus reuteri DSM 17938;Placebo;Amoxicillin-Clavulanic Acid
8 Improving Bowel Habits of Elderly With Probiotics and Non-probiotics Not yet recruiting NCT02949882 Phase 4
9 Study of Bio-K+® in the Reduction of the Risk of Clostridium Difficile Infection and Antibiotic Associated Diarrhea Terminated NCT01972932 Phase 4
10 Probiotics and the Prevention of Traveler's Diarrhea Terminated NCT01005849 Phase 4
11 Single Daily Dose Rifaximin for the Treatment of Travelers' Diarrhea Withdrawn NCT00875875 Phase 4 Rifaximin
12 Randomized Controlled Field Trial of a Probiotics to Assess Its Role in Preventig Diarrhoea Unknown status NCT00534170 Phase 3
13 Efficacy of Rifaximin in Preventing Campylobacteriosis Completed NCT02280044 Phase 2, Phase 3
14 Rifamycin SV-MMX® Tablets Versus Ciprofloxacin Capsules in Acute Traveller's Diarrhoea Completed NCT01208922 Phase 3 Rifamycin SV MMX;Ciprofloxacin
15 Safety, Immunogenicity and Efficacy of Shigella Conjugate Vaccines in 1-4 Year Olds in Israel Completed NCT00368316 Phase 3
16 Impact of Sprinkles on Infectious Morbidity When Moderate to Severe Pediatric Malnutrition Is Highly Prevalent Completed NCT00530374 Phase 3
17 Community Trial of Zinc Supplementation on Preschool Child Mortality and Morbidity in Southern Nepal Completed NCT00109551 Phase 3 zinc sulphate dietary supplement;iron sulphate-folic acid dietary supplement
18 Fermented Milk and Fermented Rice on the Appearance of Respiratory and Gastrointestinal Symptoms Completed NCT01909128 Phase 3
19 Vitamin A Supplementation in Newborns Study Completed NCT00114868 Phase 3 Vitamin A
20 Zinc Supplementation in Shigella Patients Completed NCT00321126 Phase 3 Children in the zinc group received 20 mg of elemental zinc as acetate per day in a twice-daily dose for two weeks.
21 Study of Nitazoxanide in the Treatment of Amebiasis in Children Completed NCT00366730 Phase 3 Nitazoxanide
22 Study of Nitazoxanide in the Treatment of Amebiasis in Adults and Adolescents Completed NCT00366236 Phase 3 Nitazoxanide
23 Study to Evaluate Safety and Efficacy of Rifamycin SV Multi-Matrix System (MMX) for the Treatment of Traveler's Diarrhea (TD) Completed NCT01142089 Phase 3 Placebo;Rifamycin SV MMX
24 Travelers' Diarrhea (TD) Vaccine Pivotal Efficacy Study Completed NCT00993681 Phase 3
25 Rifaximin for Prevention of Travellers' Diarrhea Completed NCT00742469 Phase 3 Rifaximin;Placebo
26 Efficacy of BIO-K+ CL1285® Prophylaxis in the Prevention of Traveler's Diarrhea in Adults Completed NCT00737412 Phase 3
27 Prevention of Travelers' Diarrhea in Subjects Traveling Outside the U.S. Completed NCT00328380 Phase 3 Rifaximin
28 Complementary Food Supplements for Reducing Childhood Undernutrition Completed NCT01562379 Phase 2, Phase 3
29 Comparison of Bovine Colostrum Versus Placebo in Treatment of Severe Alcoholic Hepatitis: A Randomized Double Blind Controlled Trial Recruiting NCT02473341 Phase 3 Bovine Colostrum;Placebo
30 Nitazoxanide Plus Lactulose Versus Lactulose Alone Treatment of Hepatic Encephalopathy Recruiting NCT02464124 Phase 2, Phase 3 Nitazoxanide;Lactulose
31 Prevention of Irinotecan Induced Diarrhea by Probiotics Recruiting NCT02819960 Phase 3 PROBIO-FIX INUM®;Placebo
32 A Study Comparing Two Rifaximin Tablets in Patients With Travelers' Diarrhea. Terminated NCT02920242 Phase 3 Rifaximin (Sandoz GmbH) tablet;Rifaximin (Xifaxan);Placebo
33 A Study to Assess the Safety, Tolerability, Effectiveness and Absorption of Exodif™ Tablets in Clostridium Difficile-associated Diarrhea Terminated NCT00466635 Phase 3 GT267-004 (tolevamer potassium sodium)
34 Clinical Trial of CBS-2004 in Prevention of Travelers' Diarrhea Withdrawn NCT02736539 Phase 3 CBS 2004 (galacto-oligosaccharides);Placebo
35 A Clinical Trial to Evaluate the Safety and Efficacy of Ciprofloxacin in the Treatment of Plague in Humans Unknown status NCT01243437 Phase 2 ciprofloxacin;doxyxcycline
36 Efficacy and Safety of CB-01-11 200mg Tablets in Infectious Diarrhoea Completed NCT03447821 Phase 2 400 mg Rifamycin SV dosage;800 mg Rifamycin SV dosage;1200 mg Rifamycin SV dosage
37 Probiotics for Infectious Diarrhea in Children in South India Completed NCT01130792 Phase 1, Phase 2
38 Isoleucine Added ORS in Children With Diarrhoea Completed NCT01034228 Phase 2
39 Safety and Efficacy Study of WRSS1, a Shigella Sonnei Vaccine Candidate Completed NCT01080716 Phase 1, Phase 2
40 Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection Completed NCT00485134 Phase 1, Phase 2
41 Effect of Irvingia Gabonensis Administration on Metabolic Syndrome, Insulin Secretion and Insulin Sensitivity Completed NCT02354339 Phase 2
42 A Study of the Safety and Immune Response of 2 Doses of a New Shigella Vaccine in Kenyan Adults Completed NCT02676895 Phase 2
43 Phase 2b Challenge Study With the Bioconjugate Vaccine Flexyn2a Completed NCT02646371 Phase 2
44 Therapeutic Induction of Endogenous Antibiotics Completed NCT00800930 Phase 2
45 Healthy Adult Volunteer Study for Two Doses of a Shigella Vaccine Completed NCT00210288 Phase 2
46 Efficacy of Combination Therapy of Glucocorticoids and Bovine Colostrum in Treatment of Severe Alcoholic Hepatitis. Completed NCT02265328 Phase 2
47 Traveler's Diarrhea (TD) Vaccine Asia Efficacy Study Completed NCT01040325 Phase 2
48 Traveler's Diarrhea (TD) Automated Process Completed NCT00751777 Phase 2
49 Rifaximin Versus Placebo in the Prevention of Travelers' Diarrhea Completed NCT00098384 Phase 2 rifaximin
50 A Study of the Absorption of GT267-004 in Patients With Clostridium Difficile-Associated Diarrhea Completed NCT00382304 Phase 2 tolevamer potassium-sodium (GT267-004)

Search NIH Clinical Center for Dysentery

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cochrane evidence based reviews: dysentery

Genetic Tests for Dysentery

Anatomical Context for Dysentery

MalaCards organs/tissues related to Dysentery:

41
Colon, Liver, Testes, Neutrophil, Breast, Bone, Bone Marrow

Publications for Dysentery

Articles related to Dysentery:

(show top 50) (show all 592)
# Title Authors Year
1
Empirical antibiotic treatment for children suffering from dysentery, cholera, pneumonia, sepsis or severe acute malnutrition. ( 29790843 )
2018
2
The other Campylobacters: Not innocent bystanders in endemic diarrhea and dysentery in children in low income settings. ( 29415075 )
2018
3
Occurrence of dysentery-like diarrhoea associated with<i>Brachyspira suanatina</i>infection in a German fattening pig farm. ( 29419486 )
2018
4
<i>Shigella</i> phages isolated during a dysentery outbreak reveal uncommon structures and broad species diversity. ( 29437962 )
2018
5
Guidelines for the treatment of dysentery (shigellosis): a systematic review of the evidence. ( 29790845 )
2018
6
Identification of a New Antimicrobial Resistance Gene Provides Fresh Insights Into Pleuromutilin Resistance in <i>Brachyspira hyodysenteriae</i>, Aetiological Agent of Swine Dysentery. ( 29971045 )
2018
7
Time Series Analysis of the Microbiota of Children Suffering From Acute Infectious Diarrhea and Their Recovery After Treatment. ( 29946306 )
2018
8
An avirulent Brachyspira hyodysenteriae strain elicits intestinal IgA and slows down spread of swine dysentery. ( 28982389 )
2017
9
Antibiotic Therapy for Acute Watery Diarrhea and Dysentery. ( 28885920 )
2017
10
Spatial-temporal detection of risk factors for bacillary dysentery in Beijing, Tianjin and Hebei, China. ( 28946856 )
2017
11
Environmental Drivers and Predicted Risk of Bacillary Dysentery in Southwest China. ( 28708077 )
2017
12
The dysentery epidemic in Poland in 1920-1921 ( 28742314 )
2017
13
A novel multiplex qPCR targeting 23S rDNA for diagnosis of swine dysentery and porcine intestinal spirochaetosis. ( 28173799 )
2017
14
The Role of Probiotics in the Treatment of Dysentery: a Randomized Double-Blind Clinical Trial. ( 28321826 )
2017
15
Seasonal and geographical distribution of bacillary dysentery (shigellosis) and associated climate risk factors in Kon Tam Province in Vietnam from 1999 to 2013. ( 28637484 )
2017
16
Geraniol as a novel antivirulence agent against bacillary dysentery-causing Shigella sonnei. ( 29256316 )
2017
17
Impacts of ambient temperature on the burden of bacillary dysentery in urban and rural Hefei, China. ( 28294081 )
2017
18
A cohort study of the effect of winter dysentery on herd-level milk production. ( 28601443 )
2017
19
An optimized swine dysentery murine model to characterize shedding and clinical disease associated with &amp;quot;Brachyspira hampsonii&amp;quot; infection. ( 28830508 )
2017
20
Assessment on the burden of bacillary dysentery associated with floods during 2005-2009 in Zhengzhou City, China, using a time-series analysis. ( 29100875 )
2017
21
Antiprotozoal Constituents from Annona cherimola Miller, a Plant Used in Mexican Traditional Medicine for the Treatment of Diarrhea and Dysentery. ( 28216899 )
2017
22
Identification of weather variables sensitive to dysentery in disease-affected county of China. ( 27742060 )
2017
23
Spatiotemporal Risk of Bacillary Dysentery and Sensitivity to Meteorological Factors in Hunan Province, China. ( 29286297 )
2017
24
Impact of meteorological factors on the incidence of bacillary dysentery in Beijing, China: A time series analysis (1970-2012). ( 28796834 )
2017
25
Comparison of the Luminal and Mucosa-Associated Microbiota in the Colon of Pigs with and without Swine Dysentery. ( 28971100 )
2017
26
Treatment rates for injectable tiamulin and lincomycin as an estimate of morbidity in a swine herd with endemic swine dysentery. ( 28487591 )
2017
27
The Effects of Floods on the Incidence of Bacillary Dysentery in Baise (Guangxi Province, China) from 2004 to 2012. ( 28208681 )
2017
28
Projected burden of disease for bacillary dysentery due to flood events in Guangxi, China. ( 28605848 )
2017
29
Residential proximity to high-density poultry operations associated with campylobacteriosis and infectious diarrhea. ( 29268955 )
2017
30
Epidemiologic Investigation of Dysentery in North of Iran: Use of Geographic Information System (GIS). ( 28144197 )
2016
31
Efficacy of Synbiotics for Treatment of Bacillary Dysentery in Children: A Double-Blind, Randomized, Placebo-Controlled Study. ( 28042600 )
2016
32
Clinical study on the efficacy of Amoebex (coded herbal drug) compared with Metronidazole for the treatment of Amoebic dysentery. ( 28375117 )
2016
33
Swine Dysentery: Etiopathogenesis and Diagnosis of a Reemerging Disease. ( 27288432 )
2016
34
Distributed lag effects and vulnerable groups of floods on bacillary dysentery in Huaihua, China. ( 27427387 )
2016
35
Association between flood and the morbidity of bacillary dysentery in Zibo City, China: a symmetric bidirectional case-crossover study. ( 27121465 )
2016
36
Patterns of Bacillary Dysentery in China, 2005-2010. ( 26828503 )
2016
37
Daily temperature change in relation to the risk of childhood bacillary dysentery among different age groups and sexes in a temperate city in China. ( 26655018 )
2016
38
Low Prevalence of Aeromonas hydrophilain Infectious Diarrhea Samples of Pediatric Patients in Arak, Iran. ( 28070529 )
2016
39
Anisakiasis Causing Acute Dysentery in Malaysia. ( 27325803 )
2016
40
Association between meteorological factors and bacillary dysentery incidence in Chaoyang city, China: an ecological study. ( 27940632 )
2016
41
Neither plague nor malaria, but dysentery as a cause of death for St. Louis. ( 26759133 )
2016
42
An Investigation into the Etiological Agents of Swine Dysentery in Australian Pig Herds. ( 27907102 )
2016
43
Quantifying the Impact of Floods on Bacillary Dysentery in Dalian City, China, From 2004 to 2010. ( 27229186 )
2016
44
Comparison of Brachyspira hyodysenteriae Isolates Recovered from Pigs in Apparently Healthy Multiplier Herds with Isolates from Herds with Swine Dysentery. ( 27489956 )
2016
45
The Use of an Autoregressive Integrated Moving Average Model for Prediction of the Incidence of Dysentery in Jiangsu, China. ( 27106828 )
2016
46
Quantitative analysis of burden of bacillary dysentery associated with floods in Hunan, China. ( 26780145 )
2016
47
The changing epidemiology of bacillary dysentery and characteristics of antimicrobial resistance of Shigella isolated in China from 2004-2014. ( 27863468 )
2016
48
Lethality of First Contact Dysentery Epidemics on Pacific Islands. ( 27185765 )
2016
49
High mean water vapour pressure promotes the transmission of bacillary dysentery. ( 25946209 )
2015
50
The association between diurnal temperature range and childhood bacillary dysentery. ( 26045331 )
2015

Variations for Dysentery

Expression for Dysentery

Search GEO for disease gene expression data for Dysentery.

Pathways for Dysentery

GO Terms for Dysentery

Cellular components related to Dysentery according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular exosome GO:0070062 9.86 ALB CRP ENO2 HP LTF PHB2
2 extracellular region GO:0005576 9.61 ALB CRP HP IFNA2 IL1A LTF
3 extracellular space GO:0005615 9.32 ALB CRP ENO2 HP IFNA2 IL1A
4 signal recognition particle receptor complex GO:0005785 9.16 LTF TF

Biological processes related to Dysentery according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cellular protein metabolic process GO:0044267 9.46 ALB LTF TF TTR
2 negative regulation by host of viral process GO:0044793 8.96 CRP LTF
3 retina homeostasis GO:0001895 8.8 ALB LTF TF

Molecular functions related to Dysentery according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 antioxidant activity GO:0016209 8.96 ALB HP
2 signal recognition particle binding GO:0005047 8.62 LTF TF

Sources for Dysentery

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....